NRX Pharmaceuticals, Inc. Cash
NRX Pharmaceuticals, Inc. (NRXP) had Cash of $1.30 million as of 2024-03-31, per its 10-Q filed 2024-05-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:Cash · last filed 2024-05-14
- 2024-03-31: Cash $1.30M.
- 2023-12-31: Cash $4.60M.
- 2023-09-30: Cash $8.90M.
- 2023-06-30: Cash $15.00M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2024-03-31 | $1.30M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $4.60M 10-K · filed 2024-03-29 | |
| 2023-09-30 | $8.90M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $15.00M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $16.50M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $20.10M 10-K · filed 2023-03-31 | |
| 2022-09-30 | $18.20M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $24.50M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $40.20M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $27.61M 10-Q · filed 2022-05-16 | |
| 2021-09-30 | $38.88M 10-Q/A · filed 2022-08-12 | |
| 2021-06-30 | $13.39M 10-Q/A · filed 2022-08-12 | |
| 2021-03-31 | $232.00 10-Q · filed 2021-05-21 | |
| 2020-12-31 | $1.86M 10-Q/A · filed 2022-08-12 | $466.00 10-K · filed 2021-04-01 |
| 2020-09-30 | $1.29M 10-Q · filed 2021-11-15 | $40.02K 10-Q · filed 2020-11-16 |
| 2020-06-30 | $995.99K 10-Q · filed 2021-08-16 | $7.00 10-Q · filed 2020-08-14 |
| 2020-03-31 | $80.77K 10-Q · filed 2021-05-21 | |
| 2019-12-31 | $877.42K 10-Q · filed 2021-11-15 | $6.00 10-K · filed 2020-03-30 |
| 2019-09-30 | $194.28K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | $1.39K 10-Q · filed 2020-08-14 | |
| 2019-03-31 | $1.82K 10-Q · filed 2020-05-15 | |
| 2018-12-31 | $11.08K 10-K/A · filed 2021-05-14 | |
| 2018-09-30 | $77.09K 10-Q · filed 2019-11-14 | |
| 2018-06-30 | $139.61K 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $267.19K 10-Q · filed 2019-05-15 | |
| 2017-12-31 | $449.37K 10-K · filed 2020-03-30 | |
| 2017-09-17 | $0.00 10-K · filed 2019-03-15 | |
| 2017-09-16 | $0.00 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |